Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Aptose Biosciences, Inc. (APTOF) had Free Cash Flow of $-21.99M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.76M |
|
-- |
|
-- |
|
$7.43M |
|
$-7.43M |
|
$-0.33M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
$-7.43M |
|
$-7.72M |
|
2.45M |
|
2.45M |
|
$-3.03 |
|
$-3.03 |
|
| Balance Sheet Financials | |
$6.45M |
|
$0.00M |
|
$3.57M |
|
$10.01M |
|
$9.31M |
|
$27.02M |
|
$27.87M |
|
$37.18M |
|
$-27.17M |
|
$-27.17M |
|
$-27.17M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-21.99M |
|
-- |
|
$19.38M |
|
$6.71M |
|
$4.10M |
|
$-2.61M |
|
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.69 |
|
-- |
|
-- |
|
-181.33 |
|
-0.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-21.99M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
28.56% |
|
28.56% |
|
-77.50% |
|
5207.38% |
|
$-10.64 |
|
$-8.99 |
|
$-8.99 |
|